Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: Remdesivir IV 200 mg once then 100 mg once daily for 9 days - XML Representation

Raw xml | Download


<Group xmlns="http://hl7.org/fhir">
  <id value="179783"/>
  <meta>
    <versionId value="3"/>
    <lastUpdated value="2023-12-04T20:29:22.185Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Group 179783</b></p><a name="179783"> </a><a name="hc179783"> </a><a name="179783-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 3; Last updated: 2023-12-04 20:29:22+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-exposure-definition.html">ExposureDefinition</a></p></div><p><b>Artifact related artifact</b>: No display for RelatedArtifact  (type: cite-as; citation: Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2023-11-30. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783.)</p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>url</b>: <a href="https://fevir.net/resources/Group/179783">https://fevir.net/resources/Group/179783</a></p><p><b>identifier</b>: FEvIR Object Identifier/179783</p><p><b>name</b>: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days</p><p><b>title</b>: Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p>
</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>membership</b>: Conceptual</p><h3>Characteristics</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td><td><b>Exclude</b></td><td><b>Description</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:">Defined by Reference</span></td><td><a href="ActivityDefinition-213.html">IV remdesivir 200 mg then 100 mg/day for 9 days</a></td><td>false</td><td><div><p>Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p>
</div></td></tr></table></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
    <valueRelatedArtifact>
      <type value="cite-as"/>
      <citation
                value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2023-11-30. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783."/>
    </valueRelatedArtifact>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name value="Brian S. Alper"/>
    </valueContactDetail>
  </extension>
  <url value="https://fevir.net/resources/Group/179783"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net"/>
    <value value="179783"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <name value="Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days"/>
  <title value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  <status value="active"/>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description
               value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <membership value="conceptual"/>
  <characteristic>
    <code>
      <text value="Defined by Reference"/>
    </code>
    <valueReference>🔗 
      <reference value="ActivityDefinition/213"/>
      <type value="ActivityDefinition"/>
      <display value="IV remdesivir 200 mg then 100 mg/day for 9 days"/>
    </valueReference>
    <exclude value="false"/>
    <description
                 value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  </characteristic>
</Group>